The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients

The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients

This work was supported by the Department of Dermatology at the Icahn School of Medicine at Mount Sinai and a grant from Regeneron and Sanofi. All funding sources reviewed and accepted the study design and the manuscript, with minimal input from Regeneron and Sanofi. Research reported in this publication was also supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number U01AI152036. Paolo Cravedi was supported by a grant from the National Institute of Allergy and Infectious Diseases under Award Number 3U01AI063594-17S1.

Saved in:
Bibliographic Details
Main Authors: Ungar, Benjamin, Hartzell, Susan, Lozano-Ojalvo, Daniel, Ghalili, Sabrina, Bose, Swaroop, Golant, Alexandra K., Tan, Kathryn, Estrada, Yeriel D., Singer, Giselle K., Pavel, Ana B., Cravedi, Paolo, Guttman-Yassky, Emma
Other Authors: Icahn School of Medicine at Mount Sinai
Format: carta al director biblioteca
Language:English
Published: Wiley-VCH 2023
Online Access:http://hdl.handle.net/10261/309582
Tags: Add Tag
No Tags, Be the first to tag this record!
id dig-cial-es-10261-309582
record_format koha
spelling dig-cial-es-10261-3095822023-05-24T12:28:53Z The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients Ungar, Benjamin Hartzell, Susan Lozano-Ojalvo, Daniel Ghalili, Sabrina Bose, Swaroop Golant, Alexandra K. Tan, Kathryn Estrada, Yeriel D. Singer, Giselle K. Pavel, Ana B. Cravedi, Paolo Guttman-Yassky, Emma Icahn School of Medicine at Mount Sinai Sanofi Sanofi España National Institute of Allergy and Infectious Diseases (US) National Institutes of Health (US) This work was supported by the Department of Dermatology at the Icahn School of Medicine at Mount Sinai and a grant from Regeneron and Sanofi. All funding sources reviewed and accepted the study design and the manuscript, with minimal input from Regeneron and Sanofi. Research reported in this publication was also supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number U01AI152036. Paolo Cravedi was supported by a grant from the National Institute of Allergy and Infectious Diseases under Award Number 3U01AI063594-17S1. Peer reviewed 2023-05-24T12:28:52Z 2023-05-24T12:28:52Z 2023 carta al director Allergy 78(2): 571-574 (2023) 0105-4538 http://hdl.handle.net/10261/309582 10.1111/all.15540 36181718 en https://doi.org/10.1111/all.15540 No none Wiley-VCH
institution CIAL ES
collection DSpace
country España
countrycode ES
component Bibliográfico
access En linea
databasecode dig-cial-es
tag biblioteca
region Europa del Sur
libraryname Biblioteca del CIAL España
language English
description This work was supported by the Department of Dermatology at the Icahn School of Medicine at Mount Sinai and a grant from Regeneron and Sanofi. All funding sources reviewed and accepted the study design and the manuscript, with minimal input from Regeneron and Sanofi. Research reported in this publication was also supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number U01AI152036. Paolo Cravedi was supported by a grant from the National Institute of Allergy and Infectious Diseases under Award Number 3U01AI063594-17S1.
author2 Icahn School of Medicine at Mount Sinai
author_facet Icahn School of Medicine at Mount Sinai
Ungar, Benjamin
Hartzell, Susan
Lozano-Ojalvo, Daniel
Ghalili, Sabrina
Bose, Swaroop
Golant, Alexandra K.
Tan, Kathryn
Estrada, Yeriel D.
Singer, Giselle K.
Pavel, Ana B.
Cravedi, Paolo
Guttman-Yassky, Emma
format carta al director
author Ungar, Benjamin
Hartzell, Susan
Lozano-Ojalvo, Daniel
Ghalili, Sabrina
Bose, Swaroop
Golant, Alexandra K.
Tan, Kathryn
Estrada, Yeriel D.
Singer, Giselle K.
Pavel, Ana B.
Cravedi, Paolo
Guttman-Yassky, Emma
spellingShingle Ungar, Benjamin
Hartzell, Susan
Lozano-Ojalvo, Daniel
Ghalili, Sabrina
Bose, Swaroop
Golant, Alexandra K.
Tan, Kathryn
Estrada, Yeriel D.
Singer, Giselle K.
Pavel, Ana B.
Cravedi, Paolo
Guttman-Yassky, Emma
The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients
author_sort Ungar, Benjamin
title The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients
title_short The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients
title_full The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients
title_fullStr The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients
title_full_unstemmed The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients
title_sort impact of dupilumab treatment on sars-cov-2 t cell responses in atopic dermatitis patients
publisher Wiley-VCH
publishDate 2023
url http://hdl.handle.net/10261/309582
work_keys_str_mv AT ungarbenjamin theimpactofdupilumabtreatmentonsarscov2tcellresponsesinatopicdermatitispatients
AT hartzellsusan theimpactofdupilumabtreatmentonsarscov2tcellresponsesinatopicdermatitispatients
AT lozanoojalvodaniel theimpactofdupilumabtreatmentonsarscov2tcellresponsesinatopicdermatitispatients
AT ghalilisabrina theimpactofdupilumabtreatmentonsarscov2tcellresponsesinatopicdermatitispatients
AT boseswaroop theimpactofdupilumabtreatmentonsarscov2tcellresponsesinatopicdermatitispatients
AT golantalexandrak theimpactofdupilumabtreatmentonsarscov2tcellresponsesinatopicdermatitispatients
AT tankathryn theimpactofdupilumabtreatmentonsarscov2tcellresponsesinatopicdermatitispatients
AT estradayerield theimpactofdupilumabtreatmentonsarscov2tcellresponsesinatopicdermatitispatients
AT singergisellek theimpactofdupilumabtreatmentonsarscov2tcellresponsesinatopicdermatitispatients
AT pavelanab theimpactofdupilumabtreatmentonsarscov2tcellresponsesinatopicdermatitispatients
AT cravedipaolo theimpactofdupilumabtreatmentonsarscov2tcellresponsesinatopicdermatitispatients
AT guttmanyasskyemma theimpactofdupilumabtreatmentonsarscov2tcellresponsesinatopicdermatitispatients
AT ungarbenjamin impactofdupilumabtreatmentonsarscov2tcellresponsesinatopicdermatitispatients
AT hartzellsusan impactofdupilumabtreatmentonsarscov2tcellresponsesinatopicdermatitispatients
AT lozanoojalvodaniel impactofdupilumabtreatmentonsarscov2tcellresponsesinatopicdermatitispatients
AT ghalilisabrina impactofdupilumabtreatmentonsarscov2tcellresponsesinatopicdermatitispatients
AT boseswaroop impactofdupilumabtreatmentonsarscov2tcellresponsesinatopicdermatitispatients
AT golantalexandrak impactofdupilumabtreatmentonsarscov2tcellresponsesinatopicdermatitispatients
AT tankathryn impactofdupilumabtreatmentonsarscov2tcellresponsesinatopicdermatitispatients
AT estradayerield impactofdupilumabtreatmentonsarscov2tcellresponsesinatopicdermatitispatients
AT singergisellek impactofdupilumabtreatmentonsarscov2tcellresponsesinatopicdermatitispatients
AT pavelanab impactofdupilumabtreatmentonsarscov2tcellresponsesinatopicdermatitispatients
AT cravedipaolo impactofdupilumabtreatmentonsarscov2tcellresponsesinatopicdermatitispatients
AT guttmanyasskyemma impactofdupilumabtreatmentonsarscov2tcellresponsesinatopicdermatitispatients
_version_ 1777671612318875648

Similar Items